Veeva Systems Inc.
General ticker "VEEV" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $41.3B (TTM average)
Veeva Systems Inc. follows the US Stock Market performance with the rate: 51.9%.
Estimated limits based on current volatility of 1.6%: low 236.84$, high 244.54$
Factors to consider:
- Total employees count: 7172 (+6.3%) as of 2024
- North America accounted for 58.7% of revenue in the fiscal year ended 2024-01-31
- Top business risk factors: Cybersecurity threats, Market competition, Customer concentration, Economic downturns and volatility, Migration challenges
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-01-31 to 2027-01-31
- 2025-01-31 to 2026-01-31 estimated range: [187.08$, 264.27$]
- 2026-01-31 to 2027-01-31 estimated range: [183.69$, 262.77$]
Financial Metrics affecting the VEEV estimates:
- Negative: with PPE of 34.6 at the end of fiscal year the price was very high
- Positive: Operating profit margin, % of 25.17 > 18.64
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: Investing cash flow per share per price, % of -1.89 <= -0.66
- Positive: Shareholder equity ratio, % of 79.46 > 63.39
- Positive: Inventory ratio change, % of -0.93 <= -0.75
- Positive: Return on assets ratio (scaled to [-100,100]) of 8.87 > 6.04
Short-term VEEV quotes
Long-term VEEV plot with estimates
Financial data
| YTD | 2023-01-31 | 2024-01-31 | 2025-01-31 |
|---|---|---|---|
| Operating Revenue | $2,155.06MM | $2,363.67MM | $2,746.62MM |
| Operating Expenses | $1,695.97MM | $1,934.34MM | $2,055.18MM |
| Operating Income | $459.09MM | $429.33MM | $691.43MM |
| Non-Operating Income | $50.01MM | $158.69MM | $227.95MM |
| R&D Expense | $520.28MM | $629.03MM | $693.08MM |
| Income(Loss) | $509.10MM | $588.02MM | $919.38MM |
| Taxes | $21.39MM | $62.32MM | $205.24MM |
| Profit(Loss)* | $487.71MM | $525.71MM | $714.14MM |
| Stockholders Equity | $3,716.25MM | $4,644.82MM | $5,832.37MM |
| Assets | $4,804.30MM | $5,910.92MM | $7,339.76MM |
| Operating Cash Flow | $780.47MM | $911.34MM | $1,090.05MM |
| Capital expenditure | $13.51MM | $26.20MM | $20.52MM |
| Investing Cash Flow | $-1,007.68MM | $-1,076.35MM | $-700.14MM |
| Financing Cash Flow | $-19.38MM | $-16.19MM | $26.11MM |
| Earnings Per Share** | $3.14 | $3.27 | $4.41 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.